Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More
The Nifty 50 may rebound after this minor correction, although consolidation appears to be ongoing. Below are some trading ideas for the near term.
Experts feel the 17,800-18,200 range is expected to break on either side after the announcement of the Budget, hence, if the Nifty breaks 18,200, then 18,500 is the level to watch out for
Indoco Remedies shares rallied more than 7 percent to Rs 415.35 and formed long bullish candle on the daily charts with strong volumes. Overall it has seen a good run up after breaking out long downward sloping resistance trend line adjoining August 12, 2021 and August 3, 2022.
GNFC is expected to be retesting a breakout of a rounding bottom formation after five years on the weekly timeframe whereas on the daily timeframe the stock is likely to be taking support from a support zone and bouncing with high volumes which can be used as a confluence towards the bullish view.
Indoco Remedies has broken out from the consolidation with jump in volumes. It has also broken out from downward sloping trendline on the weekly charts.
Indoco Remedies has given a falling trendline breakout with a rise in volume activity. The stock has broken above the previous swing high and negated the lower high lower low formation. The RSI indicator can also be seen giving a trendline breakout and confirming the bullish view.
Momentum Oscillator like RSI and MFI has witnessed trendline breakout indicates higher possibility of a sharp rise in the Globus Spirits stock prices in the coming days.
For trade in Nifty, we advise traders to wait for the prices to dip towards 18,100 –18,000 to initiate a fresh long position for an appropriate risk-reward ratio, said Rohan Patil of Bonanza Portfolio
Nifty is now placed below its 50 and 20-day exponential moving average (EMA) which is placed at 14,626 and 14,657 respectively, indicating a bearish trend for the short term.
The most noted point after September quarter earnings season was that more than 100 stocks witnessed upgrade in rating to buy from brokerages.
This Friday, Nifty continued its northward trajectory and with the help of complete gush, managed to clock fresh record highs beyond 12,300.
"We had a good broad-based rally in the market where few marquee large-cap names joined hands with quality mid-cap counters. It’s a sign of a healthy bull run, which we believe is likely to continue."
The BSE Sensex already surpassed earlier record-high and made a fresh high of 40,392.22 last week, showing over 11 percent gains from September lows.
The S&P BSE Mid-cap index gained 4.64 percent, S&P BSE Large-cap index rose 3.49 percent and the Small-cap Index was up 2.78 percent last week.
Rajesh Agarwal of AUM Capital recommends buying RBL Bank with stop loss at Rs 552 and target of Rs 567, Indoco Remedies with stop loss at Rs 194 and target of Rs 210 and Adani Gas with stop loss at Rs 105 and target of Rs 120.
Ashwani Gujral of ashwanigujral.com has a buy on Rain Industries with a stop loss of Rs 315, target of Rs 332, a buy on United Breweries with a stop loss of Rs 1090, target of Rs 1150 and a buy on Sun Pharma Advanced Research with a stop loss of Rs 410, target of Rs 435.
Jay Thakkar of Anand Rathi Securities advises buying Greaves Cotton with a target of Rs 142.75.
Jay Thakkar of Anand Rathi Securities is of the view that one may sell RBL Bank Future with a target of Rs 506.
Moneycontrol analysed pharma stocks with a market cap of over Rs 1,000 crore. In order to find out if there are any scrips available at a reasonable valuation, we used five-year average price-to-earnings as a filter
Here are a few top buzzing stocks picked by CNBC-TV18's analysts in trade today - Neuland Labs, Titan, Cyient, Indoco Remedies, Shankara Buildpro, Ashok Leyland, TVS Motor, Tata Motors, and AB Money.
Expressing concern that drug majors are running out of cash in the US market and their generics business is shrinking, Surajit Pal of Prabhudas Lilladher said he doesn‘t expect great returns from large-cap pharma stocks.
According to Ashwani Gujral of ashwanigujral.com, one can sell Indoco Remedies and Canara Bank and buy CESC.
Mahantesh Sabarad of SBI Capital Securities has a positive view on midcap pharma including Indoco Remedies.
Ashwani Gujral of ashwanigujral.com recommends selling Dish TV and Indoco Remedies and advises buying JBF Industries.
Shahina Mukadam, Independent Market Expert advises buying Zee Media Corporation with a target of Rs 24.